Evidence map›Paper›PMID 28397611›Full record

ArticleEpidemiology and infection2017

Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model.

X-M Wang, S-H Yin, J Du, M-L Du, P-Y Wang, J Wu, C M Horbinski, M-J Wu, H-Q Zheng, X-Q Xu and 2 more

Abstract read
In one paragraph

Article in Epidemiology and infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

X-M WangSchool of Public Health,Inner Mongolia Medical University,Hohhot 010110,China.
S-H YinSchool of Public Health,Inner Mongolia Medical University,Hohhot 010110,China.
J DuBeijing Tuberculosis and Thoracic Tumor Research Institute,Beijing Chest Hospital,Beijing 101149,China.
M-L DuSchool of Public Health,Inner Mongolia Medical University,Hohhot 010110,China.
P-Y WangDepartment of Social Medicine and Health Education,School of Public Health,Peking University,Beijing 100191,China.
J WuDivision for NCD Control and Prevention and Community Health,Center for Disease Control and Prevention in China,Beijing 102200,China.
C M HorbinskiFeinberg School of Medicine,Northwestern University,Chicago, IL 60611,USA.
M-J WuFeinberg School of Medicine,Northwestern University,Chicago, IL 60611,USA.
H-Q ZhengSchool of Public Health,Inner Mongolia Medical University,Hohhot 010110,China.
X-Q XuSchool of Public Health,Inner Mongolia Medical University,Hohhot 010110,China.
W ShuBeijing Tuberculosis and Thoracic Tumor Research Institute,Beijing Chest Hospital,Beijing 101149,China.
Y-J ZhangCollege of Traditional Chinese Medicine,Inner Mongolia Medical University,Hohhot 010110,China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retreatment of tuberculosis (TB) often fails in China, yet the risk factors associated with the failure remain unclear. To identify risk factors for the treatment failure of retreated pulmonary tuberculosis (PTB) patients, we analyzed the data of 395 retreated PTB patients who received retreatment between July 2009 and July 2011 in China. PTB patients were categorized into 'success' and 'failure' groups by their treatment outcome. Univariable and multivariable logistic regression were used to evaluate the association between treatment outcome and socio-demographic as well as clinical factors. We also created an optimized risk score model to evaluate the predictive values of these risk factors on treatment failure. Of 395 patients, 99 (25·1%) were diagnosed as retreatment failure. Our results showed that risk factors associated with treatment failure included drug resistance, low education level, low body mass index (6 months), standard treatment regimen, retreatment type, positive culture result after 2 months of treatment, and the place where the first medicine was taken. An Optimized Framingham risk model was then used to calculate the risk scores of these factors. Place where first medicine was taken (temporary living places) received a score of 6, which was highest among all the factors. The predicted probability of treatment failure increases as risk score increases. Ten out of 359 patients had a risk score >9, which corresponded to an estimated probability of treatment failure >70%. In conclusion, we have identified multiple clinical and socio-demographic factors that are associated with treatment failure of retreated PTB patients. We also created an optimized risk score model that was effective in predicting the retreatment failure. These results provide novel insights for the prognosis and improvement of treatment for retreated PTB patients.

Indexed as

Models, TheoreticalAdultAntitubercular AgentsChinaFemaleHumansMaleMiddle AgedRetreatmentRisk FactorsTreatment FailureTuberculosis, PulmonaryAntitubercular AgentsPulmonary tuberculosisretreatmentrisk factorsrisk score

Identifiers

PMID28397611
PMCPMC9203337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.